A new co-operation agreement between 10 South East Asia countries to standardize medical device registration will allow suppliers to take advantage of more than $400M of new emerging business in four key areas (medical imaging, clinical care, healthcare IT and consumer medical devices), according to InMedica, part of IHS.Inc (NYSE: IHS).
ST. PAUL, Minn.--(BUSINESS WIRE)--Sep 21, 2012--Smiths Medical, a leading global medical device manufacturer, today announced that its Portex® CorrectInject™ Safety System for administering neuraxial (spinal and epidural) medication received 510(k) clearance from the U.S. Food and Drug...
ERLANGEN, Germany--(BUSINESS WIRE)--Sep 21, 2012--The medical device company cerbomed GmbH from Erlangen, Germany, announces Cyberonics, Inc. as new investor and minority shareholder, with an initial investment of € 2 million. Cyberonics, Inc. – a publicly traded US company located in Houston,...
Billerica-based Bruker Corp. has acquired the in-vivo imaging equipment assets from Carestream Health Inc.’s molecular imaging business. Bruker did not disclose the financial details of the deal, but said Friday that the majority of Carestream’s employees in the imaging business will be given the chance to transition over to Bruker.
Pathogenica and California-based life sciences company Life Technologies Corp. will co-market and distribute the Boston biotech’s biodetection kit for hospital-acquired infection in Europe, the Middle East and Africa, the company said Thursday.
A contract research company for genome analysis that’s less than two months old, Genometry Inc. in Cambridge has attracted $3 million in a Series A round to fuel initial ramp-up costs.
Parexel International Corp. (Nasdaq: PRXL) is teaming up with Salem State University to offer a degree in clinical trial management, a first in the U.S. for the company, which has developed similar programs abroad for more than a decade.
Patients who underwent gastric bypass surgery had lasting weight-loss and lower incidence of diabetes that lasted for an average of 6 years following the procedure, researchers say. MASSDEVICE ON CALL — The benefits of gastric bypass surgery on severely obese patients lasted an average of 6 years following the procedure, according to a new study. Patients not only experienced significant weight loss, but had lower rates of diabetes, hypertension and high cholesterol, researchers reported. News Well, Clinical Trials, Diabetes, On Call, Research & Development, Weight lossread more
InVivo Therapeutics chief science officer Dr. Edward Wirth resigned his position after less than a year on the executive team. InVivo Therapeutics CSO steps down before 1-year anniversary News Well, Personnel, Personnel Movesread more
Pilot Study in Patients with Head and Neck Cancer Finds That Derma Sciences’ MEDIHONEY® Reduces Hospital Stays in the U.K.September 20, 2012 4:02 pm | by The Associated Press | News | Comments
PRINCETON, N.J.--(BUSINESS WIRE)--Sep 20, 2012--Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today reported an independent pilot study conducted in the U.K. showed that MEDIHONEY® may reduce the length of hospital stays by...
Navidea Awarded SBIR Grant from the NIH for Development of Radio-Immuno-Guided Surgery (RIGS) Agent Aimed at Detecting Metastatic CancerSeptember 20, 2012 4:01 pm | by The Associated Press | News | Comments
DUBLIN, Ohio--(BUSINESS WIRE)--Sep 20, 2012--Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced the receipt of a Small Business Innovation Research (SBIR) grant from the National Cancer Institute...
St. Jude Medical Receives European CE Mark Approval of Eon Mini Neurostimulator, the World’s Smallest Rechargeable Device to Treat Chronic MigraineSeptember 20, 2012 4:01 pm | by The Associated Press | News | Comments
ST. PAUL, Minn.--(BUSINESS WIRE)--Sep 20, 2012--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced it has received European CE Mark approval of its Eon ™ family of neurostimulators for patients with intractable chronic migraine. Unveiled at the European Headache...
Lawyers in a patient injury lawsuit accusing Medtronic of wrongdoing over a pain pump that left a man paralyzed renew their arguments after the case was opened for a re-hearing. Medical device industry giant Medtronic (NYSE:MDT) is back in court this month for a re-hearing of a patient injury trial accusing the company of wrongdoing that left an Arizona man paralyzed. Legal News, News Well, Drug Pumps, Personal Injuryread more
The world of medical technology has always been a rapidly changing and evolving field. Solutions for long plaguing problems, like reducing human error by using more robotics, begat more problems like an increase in mechanical failure during procedures. Plus, throw in rapidly aging baby boomers, an increase in global population, and a surge in demand for specialized doctors and the problems grow exponentially.
Aptus Endosystems said it won 510(k) clearance from the FDA for its thoracic-length HeliFX aortic anchor for repairing abdominal aortic aneurysms. The first iteration of the device earned FDA clearance – and its share of controversy – in November 2011. The latest clearance came via the watchdog agency's de novo device review protocol.